Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESAmit Rushi Is Appointed to the Role of Chief Commercial Office of...

Amit Rushi Is Appointed to the Role of Chief Commercial Office of Bodyport

April 13, 2021

Amit Rushi will serve as part of the executive team and prepare the organization for commercialization and growth.

Amit Rushi brings over two decades of medical device and digital health experience to Bodyport, with expertise in building and leading world-class commercial teams, a track record of successful product launches, and translating health technology innovation into market adoption and clinical impact.

Before joining Bodyport, Amit served as the Vice President, Commercial at Alio, and as Vice President of Strategy, Informatics, & Business Operations at Science 37. Prior to this, Amit established the Digital Health function at Medtronic Diabetes, building the data science team to drive business and product strategy. He also served on the Board of Glooko, representing Medtronic’s corporate venture investment, and led commercial functions in the Cardiovascular Division, launching multiple products and integrating acquired companies.

Amit Rushi earned both his MBA and MSIS degrees from the Questrom School of Business at Boston University and BS in business administration from the Marshall School of Business at the University of Southern California.

“I am thrilled to be joining Bodyport, to work alongside such a passionate, mission-driven, and innovative team to bring our platform to heart disease patients and their clinical teams,” said Amit Rushi. “Bodyport is pioneering an incredibly intuitive care management platform to make a meaningful difference in the quality of care for patient’s lives.”

In addition, Phyllis Whiteley, Ph.D. has been appointed to the Board. “We are excited to welcome Phyllis to be our Chair of the Board, bringing her wealth of expertise to help guide us as we move into the next phase of our growth and Amit Rushi as our CCO, to build the commercial infrastructure and market entry for Bodyport,” said Bodyport co-founder and CEO Corey Centen. “We look forward to Amit’s leadership and insights, generated from his deep experience across many sectors of healthcare, spanning both patient-centric and clinician-facing digital health chronic disease solutions.”

“I’m honored to serve as the new chair of the Bodyport Board and look forward to working closely with Corey Centen, CEO and co-founder,” said Phyllis Whiteley. “This marks a pivotal new chapter for the company, and I look forward to helping Bodyport broaden its impact. I’m excited to begin collaborating with our other board members to ensure that early detection and personalized care is available to the millions of Americans living with heart disease.”

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy